Medical and Pharmaceutical Regulus Therapeutics shares jump 135% on news of acquisition by Novartis The buyer is offering a significant premium to acquire Regulus Joseph MortonApril 30, 2025
Health & Wellness AstraZeneca to expand US manufacturing for cell therapy Investment in AstraZeneca's new Rockville Facility to propel cancer treatment research and development Zartasha MushtaqFebruary 12, 2024